Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


01.07.2019

2 Arch Phys Med Rehabil
2 BMC Neurol
1 Int J Neurosci
2 J Neurol Sci
3 Mult Scler
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Phys Med Rehabil

  1. KRAUSE JS, Dismuke-Greer CE, Reed KS, Rumrill P, et al
    Employment and job benefits among those with spinal cord dysfunction: A comparison of people with spinal cord injury and multiple sclerosis.
    Arch Phys Med Rehabil. 2019 Jun 24. pii: S0003-9993(19)30400.
    PubMed     Text format     Abstract available

  2. PLOW M, Finlayson M, Liu J, Motl RW, et al
    Randomized controlled trial of a telephone-delivered physical activity and fatigue self-management interventions in adults with multiple sclerosis.
    Arch Phys Med Rehabil. 2019 Jun 20. pii: S0003-9993(19)30397.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. FINLAYSON M, Akbar N, Turpin K, Smyth P, et al
    A multi-site, randomized controlled trial of MS INFoRm, a fatigue self-management website for persons with multiple sclerosis: rationale and study protocol.
    BMC Neurol. 2019;19:142.
    PubMed     Text format     Abstract available

  4. HONG Y, Tang HR, Ma M, Chen N, et al
    Multiple sclerosis and stroke: a systematic review and meta-analysis.
    BMC Neurol. 2019;19:139.
    PubMed     Text format     Abstract available


    Int J Neurosci

  5. HALICIOGLU S, Turkoglu SA
    Role of developmental venous anomalies in etiopathogenesis of demyelinating diseases.
    Int J Neurosci. 2019;129:245-251.
    PubMed     Text format     Abstract available


    J Neurol Sci

  6. MASUDA H, Mori M, Hirano S, Kojima K, et al
    Relapse numbers and earlier intervention by disease modifying drugs are related with progression of less brain atrophy in patients with multiple sclerosis.
    J Neurol Sci. 2019;403:78-84.
    PubMed     Text format     Abstract available

  7. SEDEEQ MS, El-Nahrery EMA, Shalaby N, Hussein M, et al
    Micro-RNA-96 and interleukin-10 are independent biomarkers for multiple sclerosis activity.
    J Neurol Sci. 2019;403:92-96.
    PubMed     Text format     Abstract available


    Mult Scler

  8. DE LOTT LB, Zerafa S, Shedden K, Dunietz GL, et al
    Multiple sclerosis relapse risk in the postoperative period: Effects of invasive surgery and anesthesia.
    Mult Scler. 2019 Jun 25:1352458519860304. doi: 10.1177/1352458519860304.
    PubMed     Text format     Abstract available

  9. INEICHEN BV, Moridi T, Granberg T, Piehl F, et al
    Rituximab treatment for multiple sclerosis.
    Mult Scler. 2019 Jun 25:1352458519858604. doi: 10.1177/1352458519858604.
    PubMed     Text format     Abstract available

  10. LEAVITT VM, Brandstadter R, Fabian M, Katz Sand I, et al
    Dissociable cognitive patterns related to depression and anxiety in multiple sclerosis.
    Mult Scler. 2019 Jun 24:1352458519860319. doi: 10.1177/1352458519860319.
    PubMed     Text format     Abstract available


    Rev Neurol

  11. PEREZ-CARMONA N, Fernandez-Jover E, Sempere AP
    [Epidemiology of multiple sclerosis in Spain].
    Rev Neurol. 2019;69:32-38.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: